Quadrupling ICS dose may reduce asthma exacerbation risk
added the 26/09/2009
Quadrupling a patient’s dose of inhaled corticosteroids (ICS) when asthma control starts to deteriorate may help reduce their risk for acute exacerbations, study findings suggest.